vimarsana.com
Home
Live Updates
FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for Biological Reference Products and Biosimilars | King & Spalding : vimarsana.com
FDA Updates Draft Guidance on Promotional Labeling and Advertising Considerations for Biological Reference Products and Biosimilars | King & Spalding
On April 25, 2024, FDA published a revised draft guidance, Promotional Labeling and Advertising Considerations for Prescription Biological Reference Products, Biosimilar Products, and...
Related Keywords
,
King Spalding
,
Promotional Labeling
,
Advertising Considerations
,
Prescription Biological Reference Products
,
Biosimilar Products
,
Interchangeable Biosimilar Products
,
Revised Draft Guidance
,
Client Alert
,
Biosimilar User Fee Amendments
,
Revised Draft
,
Draft Guidance
,
Procedures Fiscal Years
,
Prescription Biological Reference
,
vimarsana.com © 2020. All Rights Reserved.